AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 81 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $421,000 | -51.9% | 14,982 | -35.2% | 0.00% | 0.0% |
| Q2 2019 | $875,000 | -21.1% | 23,122 | -18.6% | 0.00% | -50.0% |
| Q1 2019 | $1,109,000 | +81.2% | 28,422 | -1.0% | 0.00% | +100.0% |
| Q4 2018 | $612,000 | -75.1% | 28,722 | -53.7% | 0.00% | -75.0% |
| Q3 2018 | $2,455,000 | +8.5% | 62,022 | +4.7% | 0.00% | +33.3% |
| Q2 2018 | $2,263,000 | +51.8% | 59,222 | +19.3% | 0.00% | +50.0% |
| Q1 2018 | $1,491,000 | +2.2% | 49,622 | +6.3% | 0.00% | 0.0% |
| Q4 2017 | $1,459,000 | +107.0% | 46,690 | +85.4% | 0.00% | +100.0% |
| Q3 2017 | $705,000 | +45.7% | 25,180 | -0.4% | 0.00% | 0.0% |
| Q2 2017 | $484,000 | +15.0% | 25,280 | +2.4% | 0.00% | 0.0% |
| Q1 2017 | $421,000 | +117.0% | 24,682 | +132.8% | 0.00% | – |
| Q4 2016 | $194,000 | +1.6% | 10,600 | -0.9% | 0.00% | – |
| Q3 2016 | $191,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,806,832 | $50,862,321,000 | 38.71% |
| Casdin Capital, LLC | 400,000 | $11,204,000 | 3.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,525,410 | $42,727,000 | 1.92% |
| Opaleye Management Inc. | 180,000 | $5,041,000 | 1.78% |
| Redmile Group, LLC | 1,289,332 | $36,114,000 | 1.78% |
| Cormorant Asset Management, LP | 323,545 | $9,062,000 | 1.60% |
| Orbimed Advisors | 4,129,638 | $115,671,000 | 1.10% |
| Perceptive Advisors | 1,562,618 | $43,770,000 | 0.84% |
| Rock Springs Capital Management LP | 525,000 | $14,705,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,661,000 | 0.38% |